Pf bacteriophages hinder sputum antibiotic diffusion via electrostatic binding

Qingquan Chen1, Pam Cai2, Tony Hong Wei Chang1

  • 1Division of Infectious Diseases and Geographic Medicine, Dept. of Medicine, Stanford University School of Medicine, Beckman Center, 279 Campus Drive, Stanford, CA 94305, USA.

Science Advances
|May 31, 2024
PubMed

Insights

Chronic Pseudomonas aeruginosa (Pa) infections in cystic fibrosis patients are worsened by the phage Pf, which hinders antibiotic diffusion. This study reveals how Pf and sputum polymers impede drug delivery, offering insights for new treatments.

Area of Science:

  • Microbiology
  • Biophysics
  • Pharmacology

Background:

  • Chronic Pseudomonas aeruginosa (Pa) infections are a leading cause of mortality in cystic fibrosis patients.
  • The bacteriophage Pf, a structural component of Pa biofilms, is linked to antibiotic resistance and poor outcomes in patients with cystic fibrosis (pwCF).
  • Mechanisms underlying Pf's impact on antibiotic efficacy remain unclear.

Purpose of the Study:

  • To investigate how Pf and sputum biopolymers affect antibiotic diffusion in pwCF.
  • To elucidate the interaction mechanisms between antibiotics, Pf, and sputum components.
  • To develop models for understanding antibiotic tolerance in chronic Pa infections.

Main Methods:

  • Utilized fluorescent recovery after photobleaching (FRAP) assays with pwCF sputum.
  • Studied the diffusion of tobramycin in the presence of Pf and sputum biopolymers.
  • Developed mathematical models to analyze diffusion dynamics.

Main Results:

  • Demonstrated electrostatic interactions between tobramycin, Pf, and sputum polymers.
  • Observed reduced diffusion of charged antibiotics in sputum containing Pf.
  • Identified organized liquid crystalline structures formed by Pf and sputum polymers as key to reduced diffusion.

Conclusions:

  • Pf and sputum biopolymers significantly impede charged antibiotic diffusion in pwCF.
  • Electrostatic interactions and liquid crystalline structures contribute to antibiotic tolerance.
  • Findings provide insights into therapeutic strategies for chronic Pa infections in cystic fibrosis.

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.6K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Antibiotic Selection00:57

Antibiotic Selection

Overview
53.1K
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
62.1K